[HTML][HTML] Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert …

S Rossi, A Antal, S Bestmann, M Bikson, C Brewer… - Clinical …, 2021 - Elsevier
This article is based on a consensus conference, promoted and supported by the
International Federation of Clinical Neurophysiology (IFCN), which took place in Siena (Italy) …

Using brain imaging to improve spatial targeting of transcranial magnetic stimulation for depression

RFH Cash, A Weigand, A Zalesky, SH Siddiqi… - Biological …, 2021 - Elsevier
Transcranial magnetic stimulation (TMS) is an effective treatment for depression but is
limited in that the optimal therapeutic target remains unknown. Early TMS trials lacked a …

Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression

SM McClintock, IM Reti, LL Carpenter… - The Journal of clinical …, 2017 - psychiatrist.com
Objective: To provide expert recommendations for the safe and effective application of
repetitive transcranial magnetic stimulation (rTMS) in the treatment of major depressive …

[HTML][HTML] The clinical TMS society consensus review and treatment recommendations for TMS therapy for major depressive disorder

T Perera, MS George, G Grammer, PG Janicak… - Brain stimulation, 2016 - Elsevier
Abstract Background Prefrontal Transcranial Magnetic Stimulation (TMS) therapy repeated
daily over 4–6 weeks (20–30 sessions) is US Food and Drug Administration (FDA) approved …

Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate

MD Fox, RL Buckner, MP White, MD Greicius… - Biological …, 2012 - Elsevier
BACKGROUND: Transcranial magnetic stimulation (TMS) to the left dorsolateral prefrontal
cortex (DLPFC) is used clinically for the treatment of depression. However, the …

Personalized connectivity‐guided DLPFC‐TMS for depression: Advancing computational feasibility, precision and reproducibility

RFH Cash, L Cocchi, J Lv, Y Wu… - Human brain …, 2021 - Wiley Online Library
Repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex
(DLPFC) is an established treatment for refractory depression, however, therapeutic …

Connectivity-guided intermittent theta burst versus repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled trial

R Morriss, PM Briley, L Webster, M Abdelghani… - Nature Medicine, 2024 - nature.com
Disruption in reciprocal connectivity between the right anterior insula and the left
dorsolateral prefrontal cortex is associated with depression and may be a target for …

Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research

S Rossi, M Hallett, PM Rossini, A Pascual-Leone… - Clinical …, 2009 - Elsevier
This article is based on a consensus conference, which took place in Certosa di Pontignano,
Siena (Italy) on March 7–9, 2008, intended to update the previous safety guidelines for the …

Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic …

MT Berlim, F Van den Eynde… - Psychological …, 2014 - cambridge.org
BackgroundMeta-analyses have shown that high-frequency (HF) repetitive transcranial
magnetic stimulation (rTMS) has antidepressant properties when compared with sham …

Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)

JP Lefaucheur, N André-Obadia, A Antal… - Clinical …, 2014 - Elsevier
A group of European experts was commissioned to establish guidelines on the therapeutic
use of repetitive transcranial magnetic stimulation (rTMS) from evidence published up until …